The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Respiratory Endotherapy Devices Market Projected To Expand During 2026–2030?

The market for respiratory endotherapy devices has experienced significant expansion in recent years. It is anticipated to grow from $3.32 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. This historical growth can be attributed to several factors, including the increasing prevalence of chronic respiratory diseases, a rise in lung cancer diagnosis, the expansion of interventional pulmonology, the growth of hospital endoscopy units, and the increasing demand for minimally invasive procedures.

The market for respiratory endotherapy devices is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $4.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Factors driving this projected growth include a rise in early lung screening programs, the adoption of robotic bronchoscopy, an expansion in outpatient pulmonary procedures, the integration of advanced imaging, and increasing demand for precision airway therapy. Key developments expected during this period involve minimally invasive airway intervention devices, the increasing use of disposable bronchoscopes, image-guided bronchoscopic procedures, sophisticated endobronchial ablation systems, and intelligent navigation bronchoscopy tools.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp

Which Drivers Are Advancing The Respiratory Endotherapy Devices Market Growth?

The expanding integration of robotic-assisted bronchoscopy is projected to boost the respiratory endotherapy devices market moving forward. These sophisticated robotic systems represent cutting-edge solutions, facilitating accurate navigation within the respiratory tract, which in turn elevates diagnostic precision and therapeutic results. The uptake of these systems is surging because medical professionals are increasingly looking for minimally invasive approaches that shorten procedure durations, heighten patient safety, and optimize clinical workflows. Respiratory endotherapy instruments, when augmented with robotic assistance, facilitate intricate medical procedures by offering real-time visualization, superior handling capabilities, and improved command. For example, data from September 2025, reported by the European Respiratory Society International Congress, a Switzerland-based membership organization, indicated that the application of robotic-assisted bronchoscopy coupled with integrated cone beam CT for peripheral lung lesions saw an increase to 84.6% in 2025, significantly higher than the mere 23.1% observed with conventional bronchoscopy in 2024. Consequently, the growing acceptance of robotic-assisted bronchoscopy is fueling the expansion of the respiratory endotherapy devices market.

Which Segment Groups Define The Respiratory Endotherapy Devices Market Landscape?

The respiratory endotherapy devices market covered in this report is segmented –

1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

3) By Patient Type: Adult Patients; Pediatric Patients

4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

Subsegments:

1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

What Trends Are Driving Changes In The Respiratory Endotherapy Devices Market?

Leading companies in the respiratory endotherapy devices market are concentrating on creating sophisticated solutions, such as endobronchial valves, with the aim of reducing treatment risks while achieving precise lung volume reduction without irreversible tissue removal. An endobronchial valve is a minimally invasive implant placed via bronchoscopy into selected airways to impede airflow to diseased lung areas, thereby enabling healthier regions to operate more efficiently. For instance, in February 2024, Olympus Canada Inc., a Canada-based medical technology company, launched the Spiration Valve System for the treatment of severe emphysema. This umbrella-shaped device is designed for minimally invasive bronchoscopic placement in the most affected lung regions. It uniquely diverts airflow away from hyperinflated lung areas toward healthier tissue, supporting improved respiratory mechanics. Being the sole endobronchial valve therapy presently accessible in Canada, it fulfills a critical unmet need in managing severe emphysema. Clinical data from the EMPROVE trial illustrates sustained advantages over 24 months, encompassing significant enhancements in lung function, reduced breathlessness, and an improved quality of life for patients.

Which Key Players Are Active In The Respiratory Endotherapy Devices Market?

Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

Access The Complete Respiratory Endotherapy Devices Market Report:

https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report

Which Region Commands The Largest Share Of The Respiratory Endotherapy Devices Market?

North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Respiratory Endotherapy Devices Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model